Dr Reddy’s Laboratories recalls anti-seizure, hypertension drugs from US market

Dr Reddy’s Laboratories has initiated a voluntary recall of some drugs used to treat seizure and hypertension from the US market.

The firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests, and Amlodipine Besylate and Atorvastatin Calcium tablets since these are close to expiry time.

According to a communication issued by the USFDA, the drug maker has started recalling Divalproex Sodium extended-release tablets, USP, 250 mg of 100 count (7,479 units) and 500 count bottles (2,544) units on the ground of “failed dissolution specifications, exceeded specification at the 9-hour time point”.

Also Read

Facing OTT heat, DTH operators seek pricing freedom; urge Trai for telecom sector-like forbearance

Q4 Results 2024: Tata Consumer Products, ICICI Prudential Life Insurance, and more to announce earnings today

ITC Hotels makes first overseas check-in with Colombo property

Soaring house rents push rental yields to five-year high of 4.5%

The drug, which is used to treat certain types of seizures (epilepsy), is being recalled under the “class-II” classification.

Similarly, the drug major has initiated recall of some lots of Amlodipine Besylate and Atorvastatin Calcium tablets of various strengths in 30-count and 90-count bottles manufactured at DRL’s Bachupally facility in Hyderabad, USFDA said.

The recall of these tablets is being made under “class III” classification.

Amlodipine Besylate and Atorvastatin Calcium tablets are used to treat high blood pressure (hypertension) or chest pain (angina).

For Updates Check Company News; follow us on Facebook and Twitter